397
Views
10
CrossRef citations to date
0
Altmetric
Articles

Efficacy and safety of intravenous anti-D immunoglobulin (Rhophylac®) in chronic immune thrombocytopenic purpura

, , , , , , & show all
Pages 289-295 | Published online: 04 Sep 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Vicente Escudero Vilaplana, Jorge Huerta Aragonés, Cecilia M Fernández-Llamazares, Cristina Beléndez Bieler, Silvia Manrique Rodríguez & María Sanjuro Sáez. (2012) Use of Romiplostim for Primary Immune Thrombocytopenia in Children. Pediatric Hematology and Oncology 29:2, pages 197-205.
Read now
Rahul Naithani, Rajat Kumar, M. Mahapatra, Seema Tyagi & Renu Saxena. (2009) Efficacy and safety of anti-D for treatment of adults with immune thrombocytopenia. Platelets 20:7, pages 525-527.
Read now

Articles from other publishers (8)

Ramsha Khan, Melissa Menard, Chao-Ching Jen, Xi Chen, Peter A. A. Norris & Alan H. Lazarus. (2020) Inhibition of platelet phagocytosis as an in vitro predictor for therapeutic potential of RBC antibodies in murine ITP. Blood 135:26, pages 2420-2424.
Crossref
Chayawee Muangchan, Ronald F. van Vollenhoven, Sasha R. Bernatsky, C. Douglas Smith, Marie Hudson, Murat Inanç, Naomi F. Rothfield, Peter T. Nash, Richard A. Furie, Jean‐Luc Senécal, Vinod Chandran, Ruben Burgos‐Vargas, Rosalind Ramsey‐Goldman & Janet E. Pope. (2015) Treatment Algorithms in Systemic Lupus Erythematosus. Arthritis Care & Research 67:9, pages 1237-1245.
Crossref
T. Robak, J. Trelinski, M. F. Flensburg, H. Naested & J. Petersen. (2013) Rozrolimupab, a mixture of recombinant human monoclonal anti-D antibodies, for the treatment of primary immune thrombocytopenia - a review. ISBT Science Series 8:1, pages 102-108.
Crossref
T Michelle Brown, Ruslan V Horblyuk, Kelly M Grotzinger, Axel C Matzdorff & Chris L Pashos. (2012) Patient-reported treatment burden of chronic immune thrombocytopenia therapies. BMC Blood Disorders 12:1.
Crossref
Tadeusz RobakJerzy WindygaJacek TrelinskiMario von Depka ProndzinskiAristoteles GiagounidisChantal DoyenAnn JanssensMaría Teresa Álvarez-RománIsidro JarqueJavier LoscertalesGloria Pérez RusAndrzej HellmannWiesław Wiktor JêdrzejczakKazimierz KuliczkowskiLana M. GolubovicDusica CeleketicAndrei CucuianuEmanuil GheorghitaMihaela LazaroiuOfer ShpilbergDina AttiasElena KaryaginaKalinina SvetlanaKateryna VilchevskaNichola CooperKate TalksMukhyaprana PrabhuPrasad SripadaT. P. R. Bharadwaj, Henrik Næsted, Niels J. Ø. Skartved, Torben P. Frandsen, Mimi F. Flensburg, Peter S. Andersen & Jørgen Petersen. (2012) Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia. Blood 120:18, pages 3670-3676.
Crossref
Andrew S. Kruspe, Yulia Katsman, Darinka Sakac, Cécile Chagneau, Anna Glistvain, Richard F. Langler & Donald R. Branch. (2009) Reduction of disulfide bonds within anti-D results in enhanced Fcγ receptor blockade. Transfusion 49:5, pages 928-936.
Crossref
Feng Xie, Gord Blackhouse, Nazila Assasi, Kaitryn Campbell, Mitchell Levin, Jim Bowen, Jean-Eric Tarride, David Pi & Ron Goeree. (2009) Results of a model analysis to estimate cost utility and value of information for intravenous immunoglobulin in canadian adults with chronic immune thrombocytopenic purpura. Clinical Therapeutics 31:5, pages 1082-1091.
Crossref
A. Greinacher, J. Bux & A. Salama. (2009) Autoimmune Thrombozytopenie, Neutropenie und HämolyseAutoimmune thrombocytopenia, neutropenia and hemolysis. Der Internist 50:3, pages 276-290.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.